This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Cipher Pharmaceuticals Inc.
Has received a favourable award from an extensive and comprehensive arbitration proceeding, related to a contractual dispute with Sun Pharmaceuticals Industries, Inc. regarding Sun's breach of certain provisions of its supply and distribution agreement with the Company. The contractual dispute involved Sun's launch of Absorica LD® in Canada and Sun's claim of ownership of certain clinical data. Cipher Pharmaceuticals Inc. shares T.CPH are trading up $1.08 at $15.33.
